Sagewood Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Sagewood Asset Management's VRTX Position: Q2 2026 in Review
Sagewood Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 27% in Q2 2026, buying an estimated $76.7K and bringing the position to 809 shares worth $402K. The position accounts for 0.09% of the portfolio, ranked #224.
Sagewood Asset Management first reported a position in VRTX in Q1 2026 and has held it in 2 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Sagewood Asset Management held 809 shares of Vertex Pharmaceuticals worth $402K as of Q2 2026.
- Sagewood Asset Management bought 173 Vertex Pharmaceuticals shares in Q2 2026, an estimated $76.7K.
- Vertex Pharmaceuticals made up 0.09% of Sagewood Asset Management's portfolio in Q2 2026, its #224 holding.
- Sagewood Asset Management first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Sagewood Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.